Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PSNLNASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePSNLPersonalis$3.82+6.4%$5.08$1.13▼$7.20$337.17M1.731.18 million shs971,988 shsTEMTempus AI$45.50-0.2%$54.76$22.89▼$91.45$7.84BN/A4.88 million shs12.94 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePSNLPersonalis0.00%-12.65%-27.03%-4.27%+108.72%TEMTempus AI+0.91%-13.56%-33.90%+5.53%+4,557,999,900.00%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPSNLPersonalis4.134 of 5 stars3.53.00.04.21.72.50.6TEMTempus AI2.7329 of 5 stars4.32.00.00.02.50.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePSNLPersonalis 3.00Buy$7.75102.88% UpsideTEMTempus AI 2.50Moderate Buy$61.1834.47% UpsideCurrent Analyst Ratings BreakdownLatest PSNL and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/6/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $60.003/4/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$70.00 ➝ $55.003/3/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$54.00 ➝ $60.002/28/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$8.00 ➝ $8.002/28/2025PSNLPersonalisNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.25 ➝ $7.002/26/2025TEMTempus AIWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/25/2025TEMTempus AIWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform2/25/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy2/25/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $70.002/25/2025TEMTempus AIJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$50.00 ➝ $55.002/12/2025TEMTempus AIWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPSNLPersonalis$84.61M3.98N/AN/A$2.64 per share1.45TEMTempus AI$693.40M11.30N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePSNLPersonalis-$108.30M-$1.37N/AN/AN/A-104.52%-66.07%-41.34%5/14/2025 (Estimated)TEMTempus AI-$289.81MN/A0.00N/AN/AN/AN/A-111.38%5/26/2025 (Estimated)Latest PSNL and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/2025Q4 2024PSNLPersonalis-$0.32-$0.23+$0.09-$0.23$15.48 million$16.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPSNLPersonalisN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPSNLPersonalisN/A4.684.44TEMTempus AI8.172.692.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPSNLPersonalis61.91%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipPSNLPersonalis4.10%TEMTempus AIN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePSNLPersonalis40088.26 million67.75 millionOptionableTEMTempus AI2,300172.21 millionN/AN/APSNL and TEM HeadlinesRecent News About These CompaniesTempus AI (NASDAQ:TEM) Shares Down 2.4% - What's Next?March 12 at 3:11 PM | marketbeat.comTempus AI (NASDAQ:TEM) Shares Gap Up - Should You Buy?March 12 at 12:49 PM | marketbeat.com8,702 Shares in Tempus AI, Inc. (NASDAQ:TEM) Acquired by Rakuten Securities Inc.March 12 at 7:53 AM | marketbeat.comTempus AI (NASDAQ:TEM) Stock Price Down 8.8% After Insider SellingMarch 12 at 1:17 AM | americanbankingnews.comTempus AI acquires Deep 6 AI, terms undisclosedMarch 11 at 10:47 PM | markets.businessinsider.comTempus Announces Acquisition of Deep 6 AIMarch 11 at 5:15 PM | businesswire.comTempus AI (NASDAQ:TEM) Stock Price Up 4.2% - Here's What HappenedMarch 11 at 3:32 PM | marketbeat.comRadiology AI software provider Gleamer expands into MRI with two M&A transactionsMarch 11 at 12:45 PM | msn.comWhy Tempus AI (TEM) Shares Are Soaring: The Cathie Wood EffectMarch 11 at 12:45 PM | msn.comRadiology AI software provider Gleamer expands into MRI with two small acquisitionsMarch 11 at 2:23 AM | techcrunch.comTempus AI (NASDAQ:TEM) Trading Down 8.8% After Insider SellingMarch 10 at 11:20 AM | marketbeat.comTempus AI (NASDAQ:TEM) Trading Down 3% Following Insider SellingMarch 9 at 1:39 AM | americanbankingnews.comEric P. Lefkofsky Sells 562,345 Shares of Tempus AI, Inc. (NASDAQ:TEM) StockMarch 8, 2025 | insidertrades.comWhy Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much?March 8, 2025 | finance.yahoo.comTempus AI, Inc. (TEM): Among The Stocks With At Least $10 Million In Insider Sales RecentlyMarch 7, 2025 | insidermonkey.comTempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 562,345 SharesMarch 7, 2025 | marketbeat.comTempus AI (NASDAQ:TEM) Shares Down 3% After Insider SellingMarch 7, 2025 | marketbeat.comInsider Selling: Tempus AI, Inc. (NASDAQ:TEM) Director Sells 809 Shares of StockMarch 7, 2025 | insidertrades.comTempus AI, Inc. (NASDAQ:TEM) Shares Bought by Vestmark Advisory Solutions Inc.March 7, 2025 | marketbeat.comTempus AI (NASDAQ:TEM) Stock Price Down 3.1% After Analyst DowngradeMarch 7, 2025 | americanbankingnews.comTempus AI price target raised to $60 from $50 at Morgan StanleyMarch 6, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPrice Targets on NVIDIA Rise in Front of EarningsBy Sarah Horvath | February 24, 2025View Price Targets on NVIDIA Rise in Front of EarningsWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentBy Gabriel Osorio-Mazilli | February 14, 2025View NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentConflicting Signals: Tempus AI's Stock Market Rally By Jeffrey Neal Johnson | February 17, 2025View Conflicting Signals: Tempus AI's Stock Market Rally Tempus AI Is a Buy, If You Can Handle the VolatilityBy Thomas Hughes | February 26, 2025View Tempus AI Is a Buy, If You Can Handle the VolatilityPSNL and TEM Company DescriptionsPersonalis NASDAQ:PSNL$3.82 +0.23 (+6.41%) Closing price 04:00 PM EasternExtended Trading$3.82 +0.01 (+0.13%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.Tempus AI NASDAQ:TEM$45.50 -0.08 (-0.18%) Closing price 04:00 PM EasternExtended Trading$46.14 +0.63 (+1.40%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
